RxDoctor Payments Data

Amrit Vinod, MD

Sports Medicine · Chicago, ILNPI 1477087997

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (45.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Smith+Nephew at 48.8% of the total. Reporting peaked in 2023 at $6,149 and has fallen 71.8% since, to $1,733 in 2025.

$11,488in general payments, 2019–2025

Across 77 payments — averaging $149.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$6K
  • Arthrex$3K
  • Kairos Surgical Inc$2K
  • Vericel Corporation$579
  • Stryker$179

What the payments were for

  • Travel & lodging$4,01835%
  • Food & beverage$2,27020%
  • Education$5,20045%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew3$5,601
Arthrex46$2,894
Kairos Surgical Inc21$2,234
Vericel Corporation4$579
Stryker3$179

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,488 in reported general payments places this provider in the 75th percentile of 233 sports medicine providers in Illinois.

See all sports medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$95,184
Medicare patients
295
Services billed
10,920

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen28$194
Meloxicam16$47
Oxycodone Hcl11$36

Paid to pharmacies, not to this prescriber.

Other sports medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →